A Post-Marketing Observational Study to Evaluate the Effectiveness of Adalimumab in Patients With Moderately to Severely Active Rheumatoid Arthritis in China

NCT01464021 · clinicaltrials.gov ↗

TERMINATED

Status

26

Enrollment

INDUSTRY

Sponsor class

Stopped This study was prematurely terminated due to low enrollment

Conditions

Arthritis
Rheumatoid

Sponsor

AbbVie (prior sponsor, Abbott)